Hypersensitivity reactions associated with oxaliplatin
Author:
- 15 August 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 5 (5) , 687-694
Abstract
The reported incidence of hypersensitivity reactions (HSRs) associated with oxaliplatin in patients with colorectal cancer (CRC) is ~ 12%, with 1 – 2% of patients developing grade 3 or 4 in severity. However, the recent rising incidence of HSR to oxaliplatin observed is the result of increasing clinical use. HSR to oxaliplatin may manifest as facial flushing, rash/hives, tachycardia, dyspnoea, erythema, pruritis, fever, tongue swelling, headache, chills, weakness, vomiting, burning sensations, dizziness and oedema. Anaphylactic shock is rare but serious, and must be considered in the event of hypotension. No definitive approaches to prevent and treat HSR associated with oxaliplatin are available; however, few successful strategies have been reported. Such strategies include: slowing the infusion rate, use of steroids and antagonists of type 1 and 2 histamine receptors, and desensitisation. Successful implementation of oxaliplatin desensitisation protocols based on other platinum-containing compounds have ...Keywords
This publication has 28 references indexed in Scilit:
- Hypersensitivity reactions to oxaliplatin: experience in a single instituteAnnals of Oncology, 2005
- Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patientsEuropean Journal of Cancer, 2005
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon CancerNew England Journal of Medicine, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Hypersensitivity reactions related to oxaliplatin (OHP)British Journal of Cancer, 2003
- Hypersensitivity and idiosyncratic reactions to oxaliplatinCancer, 2003
- Hypersensitivity Reactions to Chemotherapeutic DrugsClinical Reviews in Allergy & Immunology, 2003
- Anaphylaxis to cisplatin following nine previous uncomplicated cyclesInternational Journal of Clinical Oncology, 2002
- Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic MalignanciesGynecologic Oncology, 2001
- Oxaliplatin-Induced Fever and Release of IL-6Oncology, 2000